Increased Insulin Resistance and Serum Resistin in Korean Patients with Behçet's Disease

Archives of Medical Research

Volumn 41, Issue 4, 2010, Pages 269-274

  Kim, Seong Kyu ^a   Choe, Jung Yoon ^a   Park, Sung Hoon ^a   Lee, Sung Won ^b   Lee, Geon Ho ^a   Chung, Won Tae ^b  

^a Catholic University of Daegu   (South Korea)

^b Dong A University College of Medicine   (South Korea)

Author keywords

Beh et's disease; HOMA IR; Insulin resistance; Metabolic syndrome; Resistin

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; RESISTIN;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ASSESSMENT; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INFORMATION PROCESSING; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION; BLOOD; CASE CONTROL STUDY; PATHOPHYSIOLOGY; RISK FACTOR;

ADIPONECTIN; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; KOREA; MALE; RESISTIN; RISK FACTORS;

EID: 77954625588     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.05.008     Document Type: Article

References (32)

1. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
2. Uysal K.T., Wiesbrock S.M., Marino M.W., et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 1997, 389:610-614.
3. Bastard J.P., Maachi M., Van Nhieu J.T., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002, 87:2084-2089.
4. Chung C.P., Oeser A., Solus J.F., et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008, 196:756-763.
5. La Montagna G., Cacciapuoti F., Buono R., et al. Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diab Vasc Dis Res 2007, 4:130-135.
6. El Magadmi M., Ahmad Y., Turkie W., et al. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol 2006, 33:50-56.
7. Vadacca M., Margiotta D., Rigon A., et al. Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors. J Rheumatol 2009, 36:295-297.
8. Malesci D., Niglio A., Mennillo G.A., et al. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 2007, 26:710-714.
9. Sakane T., Takeno M., Suzuki N., et al. Behcet's disease. N Engl J Med 1999, 341:1284-1291.
10. International Study Group for Behcet's disease Criteria for diagnosis of Behcet's disease. Lancet 1990, 335:1078-1080.
11. Zouboulis C.C., Katsantonis J., Ketteler R., et al. Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000, 292:279-284.
12. Evereklioglu C., Er H., Türköz Y., et al. Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Mediators Inflamm 2002, 11:87-93.
13. Oguz A., Dogan E.G., Uzunlulu M., et al. Insulin resistance and adiponectin levels in Behçet's syndrome. Clin Exp Rheumatol 2007, 25(4 Suppl. 45):S118-S119.
14. Erdem H., Dinc A., Pay S., et al. Peripheral insulin resistance in patients with Behçet's disease. J Eur Acad Dermatol Venereol 2006, 20:391-395.
15. Zhang Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
16. Lago F., Dieguez C., Gómez-Reino J., et al. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007, 18:313-325.
17. Statnick M.A., Beavers L.S., Conner L.J., et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 2000, 1:81-88.
18. Senolt L., Housa D., Vernerová Z., et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007, 66:458-463.
19. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
20. Yalçindag F.N., Yalçindag A., Batioglu F., et al. Evaluation of serum resistin levels in patients with ocular and non-ocular Behçet's disease. Can J Ophthalmol 2008, 43:473-475.
21. Evereklioglu C., Inalöz H.S., Kirtak N., et al. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity. Br J Dermatol 2002, 147:331-336.
22. International Study Group for Behçet's disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080.
23. Gül A., Esin S., Dilsen N., et al. Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol 1995, 132:901-907.
24. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
25. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
26. World Health Organisation, Western Pacific Region, The Asia-Pacific Perspective. Redefining Obesity and its Treatment, WHO/IASO/IOTF, 2000.
27. Festa A., D'Agostino R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.
28. Temelkova-Kurktschiev T., Siegert G., Bergmann S., et al. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism 2002, 51:743-749.
29. Hotamisligil G.S., Arner P., Caro J.F., et al. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995, 95:2409-2415.
30. Pickup J.C., Mattock M.B., Chusney G.D., et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40:1286-1292.
31. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
32. Gonzalez-Gay M.A., Llorca J., Garcia-Unzueta M.T., et al. High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clin Exp Rheumatol 2008, 26:596-603.